Format

Send to

Choose Destination
Lancet. 2014 Mar 15;383(9921):999-1008. doi: 10.1016/S0140-6736(13)61752-3. Epub 2013 Sep 29.

The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.

Author information

1
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
2
National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA; Population Research Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
3
National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA; Department of Medicine and Whitaker Cardiovascular Institute, School of Medicine, Boston University, Boston, MA, USA.
4
National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA. Electronic address: thomas.j.wang@vanderbilt.edu.

Abstract

On Sept 29, 2013, the Framingham Heart Study will celebrate 65 years since the examination of the first volunteer in 1948. During this period, the study has provided substantial insight into the epidemiology and risk factors of cardiovascular disease. The origins of the study are closely linked to the cardiovascular health of President Franklin D Roosevelt and his premature death from hypertensive heart disease and stroke in 1945. In this Review we describe the events leading to the foundation of the Framingham Heart Study, and provide a brief historical overview of selected contributions from the study.

PMID:
24084292
PMCID:
PMC4159698
DOI:
10.1016/S0140-6736(13)61752-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center